Advertisement
Screener

Theriva Biologics, Inc. (TOVX) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

Theriva Biologics, Inc. Earnings Per Share (Basic)

Theriva Biologics, Inc. (TOVX) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-08-11

  • Theriva Biologics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
  • Theriva Biologics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.05.
  • Theriva Biologics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.12.
  • Theriva Biologics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.45.
  • Theriva Biologics, Inc. earnings per share, basic for fiscal 2025 was -$2.08.
  • Theriva Biologics, Inc. earnings per share, basic for fiscal 2024 was -$19.03.
  • Theriva Biologics, Inc. earnings per share, basic for fiscal 2023 was -$28.48.
  • Theriva Biologics, Inc. earnings per share, basic for fiscal 2022 was -$1.31.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 6 month as first filedEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 9 month as first filedEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2026-06-30-$0.07
10-Q · filed 2026-08-11
-$0.12
10-Q · filed 2026-08-11
-$0.23
derived: net income ÷ weighted average shares · filed 2026-08-11
-$0.42
derived: net income ÷ weighted average shares · filed 2026-08-11
2026-03-31-$0.05
10-Q · filed 2026-05-05
-$0.16
derived: net income ÷ weighted average shares · filed 2026-05-05
-$0.37
derived: net income ÷ weighted average shares · filed 2026-05-05
-$1.06
derived: net income ÷ weighted average shares · filed 2026-08-11
2025-12-31-$0.12
derived: net income ÷ weighted average shares · filed 2026-03-12
-$0.40
derived: net income ÷ weighted average shares · filed 2026-03-12
-$1.37
derived: net income ÷ weighted average shares · filed 2026-08-11
-$2.08
10-K · filed 2026-03-12
2025-09-30-$0.45
10-Q · filed 2025-11-12
-$2.12
derived: net income ÷ weighted average shares · filed 2026-08-11
-$3.38
10-Q · filed 2025-11-12
-$4.76
derived: net income ÷ weighted average shares · filed 2026-08-11
2025-06-30-$1.93
10-Q · filed 2026-08-11
-$3.64
10-Q · filed 2026-08-11
-$5.31
derived: net income ÷ weighted average shares · filed 2026-08-11
-$8.78
derived: net income ÷ weighted average shares · filed 2026-08-11
2025-03-31-$1.55
10-Q · filed 2026-05-05
-$3.15
derived: net income ÷ weighted average shares · filed 2026-05-05
-$7.38
derived: net income ÷ weighted average shares · filed 2026-05-05
-$13.26
derived: net income ÷ weighted average shares · filed 2026-05-05
2024-12-31-$1.59
derived: net income ÷ weighted average shares · filed 2026-03-12
-$6.20
derived: net income ÷ weighted average shares · filed 2026-03-12
-$13.07
derived: net income ÷ weighted average shares · filed 2026-03-12
-$19.03
10-K · filed 2026-03-12
2024-09-30-$6.81
10-Q · filed 2025-11-12
-$16.80
derived: net income ÷ weighted average shares · filed 2025-11-12
-$24.47
10-Q · filed 2025-11-12
-$32.56
derived: net income ÷ weighted average shares · filed 2025-11-12
2024-06-30-$10.72
10-Q · filed 2025-08-11
-$0.43
10-Q · filed 2024-08-13
-$18.45
10-Q · filed 2025-08-11
-$0.74
10-Q · filed 2024-08-13
-$26.53
derived: net income ÷ weighted average shares · filed 2025-08-11
-$31.52
derived: net income ÷ weighted average shares · filed 2025-08-11
2024-03-31-$7.53
10-Q · filed 2025-05-14
-$0.30
10-Q · filed 2024-05-07
-$15.56
derived: net income ÷ weighted average shares · filed 2025-05-14
-$20.41
derived: net income ÷ weighted average shares · filed 2025-05-14
-$4.42
derived: net income ÷ weighted average shares · filed 2025-05-14
2023-12-31-$8.03
derived: net income ÷ weighted average shares · filed 2025-03-06
-$12.88
derived: net income ÷ weighted average shares · filed 2025-03-06
-$2.52
derived: net income ÷ weighted average shares · filed 2025-03-06
-$28.48
10-K · filed 2025-03-06
-$1.14
10-K · filed 2024-03-25
2023-09-30-$4.85
10-Q · filed 2024-11-12
-$0.19
10-Q · filed 2023-11-13
-$1.06
derived: net income ÷ weighted average shares · filed 2024-11-12
-$20.38
10-Q · filed 2024-11-12
-$0.81
10-Q · filed 2023-11-13
-$1.65
derived: net income ÷ weighted average shares · filed 2024-11-12
2023-06-30-$0.34
10-Q · filed 2024-08-13
-$0.63
10-Q · filed 2024-08-13
-$1.04
derived: net income ÷ weighted average shares · filed 2024-08-13
-$1.35
derived: net income ÷ weighted average shares · filed 2024-08-13
2023-03-31-$0.30
10-Q · filed 2024-05-07
-$0.71
derived: net income ÷ weighted average shares · filed 2024-05-07
-$1.01
derived: net income ÷ weighted average shares · filed 2024-05-07
-$1.29
derived: net income ÷ weighted average shares · filed 2024-05-07
2022-12-31-$0.41
derived: net income ÷ weighted average shares · filed 2024-03-25
-$0.71
derived: net income ÷ weighted average shares · filed 2024-03-25
-$1.00
derived: net income ÷ weighted average shares · filed 2024-03-25
-$1.31
10-K · filed 2024-03-25
2022-09-30-$0.30
10-Q · filed 2023-11-13
-$0.33
10-Q · filed 2022-11-10
-$0.59
derived: net income ÷ weighted average shares · filed 2023-11-13
-$0.87
10-Q · filed 2023-11-13
-$0.95
10-Q · filed 2022-11-10
-$1.28
derived: net income ÷ weighted average shares · filed 2023-11-13
2022-06-30-$0.28
10-Q · filed 2023-08-08
-$0.31
10-Q · filed 2022-08-11
-$0.59
10-Q · filed 2023-08-08
-$0.62
10-Q · filed 2022-08-11
-$0.98
derived: net income ÷ weighted average shares · filed 2023-08-08
-$1.23
derived: net income ÷ weighted average shares · filed 2023-08-08
2022-03-31-$0.31
10-Q · filed 2023-05-11
-$0.03
10-Q · filed 2022-05-16
-$0.71
derived: net income ÷ weighted average shares · filed 2023-05-11
-$0.95
derived: net income ÷ weighted average shares · filed 2023-05-11
-$1.20
derived: net income ÷ weighted average shares · filed 2023-05-11
2021-12-31-$0.40
derived: net income ÷ weighted average shares · filed 2023-03-30
-$0.65
derived: net income ÷ weighted average shares · filed 2023-03-30
-$0.89
derived: net income ÷ weighted average shares · filed 2023-03-30
-$1.90
10-K · filed 2023-03-30
-$0.19
10-K · filed 2022-03-16
2021-09-30-$0.25
10-Q · filed 2022-11-10
-$0.02
10-Q · filed 2021-11-03
-$0.49
derived: net income ÷ weighted average shares · filed 2022-11-10
-$1.51
10-Q · filed 2022-11-10
-$0.15
10-Q · filed 2021-11-03
-$0.61
derived: net income ÷ weighted average shares · filed 2022-11-10
2021-06-30-$0.24
10-Q · filed 2022-08-11
-$1.31
10-Q · filed 2022-08-11
-$0.43
derived: net income ÷ weighted average shares · filed 2022-08-11
-$0.57
derived: net income ÷ weighted average shares · filed 2022-08-11
2021-03-31-$0.13
10-Q · filed 2022-05-16
-$0.26
derived: net income ÷ weighted average shares · filed 2022-05-16
-$0.39
derived: net income ÷ weighted average shares · filed 2022-05-16
2020-12-31-$0.15
derived: net income ÷ weighted average shares · filed 2022-03-16
-$0.29
derived: net income ÷ weighted average shares · filed 2022-03-16
-$0.66
10-K · filed 2022-03-16
2020-09-30-$0.14
10-Q · filed 2021-11-03
-$0.52
10-Q · filed 2021-11-03
2019-09-30-$0.31
10-Q · filed 2019-11-04
-$0.54
derived: net income ÷ weighted average shares · filed 2020-11-10
-$0.79
10-Q · filed 2019-11-04
-$1.79
derived: net income ÷ weighted average shares · filed 2020-11-10
2019-06-30-$0.23
10-Q · filed 2019-08-08
-$0.48
10-Q · filed 2019-08-08
-$1.49
derived: net income ÷ weighted average shares · filed 2020-08-06
-$2.12
derived: net income ÷ weighted average shares · filed 2020-08-06
2019-03-31-$0.25
10-Q · filed 2019-05-08
-$1.30
derived: net income ÷ weighted average shares · filed 2020-05-05
-$2.05
derived: net income ÷ weighted average shares · filed 2020-05-05
-$2.92
derived: net income ÷ weighted average shares · filed 2020-05-05
2018-12-31-$1.12
10-K · filed 2019-02-27
-$2.14
derived: net income ÷ weighted average shares · filed 2020-02-20
-$3.25
derived: net income ÷ weighted average shares · filed 2020-02-20
-$4.07
derived: net income ÷ weighted average shares · filed 2020-02-20
2018-09-30-$0.93
10-Q · filed 2019-11-04
-$2.07
derived: net income ÷ weighted average shares · filed 2019-11-04
-$2.73
10-Q · filed 2019-11-04
-$2.01
derived: net income ÷ weighted average shares · filed 2019-11-04
2018-06-30-$1.16
10-Q · filed 2019-08-08
-$0.03
10-Q · filed 2018-08-08
-$1.80
10-Q · filed 2019-08-08
-$0.05
10-Q · filed 2018-08-08
-$1.05
derived: net income ÷ weighted average shares · filed 2019-08-08
-$5.90
derived: net income ÷ weighted average shares · filed 2019-08-08
2018-03-31-$0.65
10-Q · filed 2019-05-08
-$0.02
10-Q · filed 2018-05-08
$0.11
derived: net income ÷ weighted average shares · filed 2019-05-08
-$4.74
derived: net income ÷ weighted average shares · filed 2019-05-08
-$5.97
derived: net income ÷ weighted average shares · filed 2019-05-08
2017-12-31$0.76
10-K · filed 2019-02-27
$0.02
10-K · filed 2018-02-22
-$4.10
derived: net income ÷ weighted average shares · filed 2019-02-27
-$5.33
derived: net income ÷ weighted average shares · filed 2019-02-27
-$6.23
derived: net income ÷ weighted average shares · filed 2019-02-27
2017-09-30-$4.90
10-K · filed 2019-02-27
-$0.14
10-Q · filed 2017-11-01
-$6.15
derived: net income ÷ weighted average shares · filed 2019-02-27
-$7.00
10-Q · filed 2018-11-08
-$0.20
10-Q · filed 2017-11-01
-$0.96
derived: net income ÷ weighted average shares · filed 2019-02-27
2017-06-30-$1.05
10-K · filed 2019-02-27
-$0.03
10-Q · filed 2017-08-03
-$0.06
10-Q · filed 2018-08-08
-$0.26
derived: net income ÷ weighted average shares · filed 2019-02-27
-$0.35
derived: net income ÷ weighted average shares · filed 2019-02-27
2017-03-31-$0.70
10-K · filed 2019-02-27
-$0.02
10-Q · filed 2017-05-04
-$0.10
derived: net income ÷ weighted average shares · filed 2019-02-27
-$0.21
derived: net income ÷ weighted average shares · filed 2019-02-27
-$0.27
derived: net income ÷ weighted average shares · filed 2019-02-27
2016-12-31-$0.02
10-K · filed 2018-02-22
-$0.11
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.17
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.29
derived: net income ÷ weighted average shares · filed 2018-02-22
2016-09-30-$0.09
10-K · filed 2018-02-22
-$0.15
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.27
10-Q · filed 2017-11-01
-$0.39
derived: net income ÷ weighted average shares · filed 2018-02-22
2016-06-30-$0.06
10-K · filed 2018-02-22
-$0.18
10-Q · filed 2017-08-03
-$0.30
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.38
derived: net income ÷ weighted average shares · filed 2018-02-22
2016-03-31-$0.12
10-K · filed 2018-02-22
-$0.24
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.32
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.50
derived: net income ÷ weighted average shares · filed 2018-02-22
2015-12-31-$0.12
10-K · filed 2017-03-02
-$0.20
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.38
derived: net income ÷ weighted average shares · filed 2018-02-22
-$0.54
derived: net income ÷ weighted average shares · filed 2018-02-22
2015-09-30-$0.08
10-K · filed 2017-03-02
-$0.26
derived: net income ÷ weighted average shares · filed 2017-03-02
-$0.42
10-Q · filed 2016-11-01
2015-06-30-$0.19
10-K · filed 2017-03-02
-$0.36
10-Q · filed 2016-08-03
2015-03-31-$0.17
10-K · filed 2017-03-02
2014-09-30-$0.08
10-Q · filed 2015-11-05
-$0.23
10-Q · filed 2015-11-05
2011-06-30-$0.06
10-Q · filed 2011-08-15
-$0.15
10-Q · filed 2011-08-15
2010-06-30$0.05
10-Q · filed 2011-08-15
$0.00
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
KALA BIO, Inc. (KALA)United States$0.011B-3.33
MetaVia Inc. (MTVA)United States$0.011B-0.65
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Medicus Pharma Ltd. (MDCX)$0.010B
Dare Bioscience, Inc. (DARE)United States$0.011B
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92